News
What if one of the most promising compounds for colorectal cancer… isn’t a drug—but a cannabinoid most people have never even heard of?
CBG (the “mother cannabinoid”) is quietly showing powerful anti-tumor effects in early research—slowing cancer growth, triggering cell death, and targeting pathways specific to colon cancer. But here’s the catch: it doesn’t work in isolation.
The real shift happens when you combine targeted cannabinoids, gut-healing nutrition, and anti-inflammatory lifestyle changes into one strategic protocol. Because when it comes to colorectal cancer, healing isn’t about one miracle solution—it’s about changing the entire environment cancer depends on.
Today’s blog will focus on the endocannabinoid system and its mechanism as a bridge between the bacteria and the body itself – especially in the relay to communication with the brain – a subject that has received a distinct lack of attention outside of scientific journals.
As in any system, imbalance causes problems. Humans need a steady stream of bacteria to maintain a healthy gut microbiome, these bacteria help break down the foods we eat and allow nutrients to be readily absorbed in the digestive tract. Other mitigating factors that influence the microbiome are exercise, diet, pharmaceuticals, and the consumption of cannabis or hemp.
We will let you guess which of these factors will result in a healthy gut biome vs. one considered imbalanced, or impaired.
